These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 4293530)

  • 1. [The level of oxypurines in the plasma and urine of control and gout patients. (Correlation with the level of uric acid)].
    Auscher C; Brouilhet H; Delbarre F
    Sem Hop; 1967 Apr; 43(17):1123-6. PubMed ID: 4293530
    [No Abstract]   [Full Text] [Related]  

  • 2. [Analysis of uric acid and oxypurines in normal subjects and in gout patients].
    Porcelli B; Pizzichini M; Di Stefano A; Leoncini R; Taddeo A; Marinello E
    Boll Soc Ital Biol Sper; 1989 Dec; 65(12):1201-5. PubMed ID: 2627336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Behavior of plasma and urine purines, after a purine-free diet, in normal subjects and patients with gout].
    Vannoni D; Porcelli B; Di Stefano A; Pizzichini M; Leoncini R; Terzuoli L; Taddeo A; Marsini S; Morozzi G; Marcolongo R
    Medicina (Firenze); 1989; 9(3):295-7. PubMed ID: 2615605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clearance of oxypurines in normal subjects and in gout patients subjected to a purine-free diet. Effects of allopurinol].
    Porcelli B; Pizzichini M; Di Stefano A; Leoncini R; Taddeo A; Marinello E
    Boll Soc Ital Biol Sper; 1989 Nov; 65(11):1105-10. PubMed ID: 2629828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The behavior of oxypurines in human primary gout.
    Aleo MF; Pompucci G; D'Amato MS; Marcolongo R; Marinello E
    Quad Sclavo Diagn; 1983 Jun; 19(2):235-41. PubMed ID: 6676773
    [No Abstract]   [Full Text] [Related]  

  • 6. Impaired renal excretion of hypoxanthine and xanthine in primary gout.
    Puig JG; Mateos FA; Jiménez ML; Ramos T; Capitán MC; Gil AA
    Adv Exp Med Biol; 1989; 253A():269-76. PubMed ID: 2624202
    [No Abstract]   [Full Text] [Related]  

  • 7. [Purine metabolism in human tumors].
    Vannoni D; Porcelli B; Caldarone R; Garzi A
    Medicina (Firenze); 1989; 9(1):51-4. PubMed ID: 2739532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of prednisolone on urate and oxypurine excretion.
    Hisatome I; Ishiko R; Sasaki N; Kotake H; Kobayashi M; Ogino K; Hasegawa J; Yoshida A; Shigemasa C; Mashiba H
    Horm Metab Res; 1991 Oct; 23(10):513-4. PubMed ID: 1761287
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of probenecid on oxypurines in plasma.
    Yamamoto T; Takahashi S; Suda M; Hada T; Higashino K
    Int J Clin Pharmacol Ther Toxicol; 1989 Oct; 27(10):510-4. PubMed ID: 2511159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of oxypurines by HPLC in lymphoproliferative diseases.
    Marinello E; Vannoni D; Porcelli B; Dispensa E
    Adv Exp Med Biol; 1989; 253A():407-10. PubMed ID: 2624220
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of the xanthine oxidase inhibitor, allopurinol, in the control of hyperuricaemia, gout and uric acid calculi.
    Emmerson BT
    Australas Ann Med; 1967 Aug; 16(3):205-14. PubMed ID: 6056609
    [No Abstract]   [Full Text] [Related]  

  • 12. Behavior of oxypurines in normal subjects after an 8 day purine-free diet.
    Marinello E; Porcelli B; Vannoni D; Taddeo A
    Adv Exp Med Biol; 1989; 253A():239-42. PubMed ID: 2624198
    [No Abstract]   [Full Text] [Related]  

  • 13. Allopurinol in treatment of patients with gout and chronic renal failure.
    Bowie EA; Simmonds HA; North JD
    N Z Med J; 1967 Sep; 66(421):606-11. PubMed ID: 5234549
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal excretion of hypoxanthine and xanthine in primary gout.
    Puig JG; Mateos FA; Jiménez ML; Ramos TH
    Am J Med; 1988 Oct; 85(4):533-7. PubMed ID: 3177401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allopurinol in patients with impaired renal function.
    Levin NW; Abrahams OL
    Ann Rheum Dis; 1966 Nov; 25(6 Suppl):681-7. PubMed ID: 5958698
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clearance of oxypurines and uric acid in patients with gout].
    Vannoni D; Porcelli B; Di Stefano A; Pizzichini M; Leoncini R; Terzuoli L; Taddeo A; Marsini S; Morozzi G; Marcolongo R
    Medicina (Firenze); 1989; 9(3):297-9. PubMed ID: 2615606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous measurement of plasma and erythrocyte oxypurines. II. Gouty patients with and without allopurinol medication.
    Hayashi TT; Gillo D; Turner JH; Rodnan GP
    Gynecol Invest; 1972; 3(5):221-36. PubMed ID: 4656975
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal hypouricemia associated with hyperoxypurinemia due to decreased renal excretion of oxypurines: a new defect in renal purine transport.
    Kawachi M; Kono N; Mineo I; Kiyokawa H; Nakajima H; Shimizu T; Ono A; Nishimura T; Yorifuji S; Kuwajima M
    Adv Exp Med Biol; 1991; 309A():239-42. PubMed ID: 1789216
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma and urinary oxypurines in Lesch-Nyhan patient after allopurinol treatment.
    Roscioni G; Farnetani MA; Pagani R; Pizzichini M; Marinello E; Porcelli B
    Adv Exp Med Biol; 1994; 370():357-61. PubMed ID: 7660928
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma concentrations and urinary excretion of purine bases (uric acid, hypoxanthine, and xanthine) and oxypurinol after rigorous exercise.
    Kaya M; Moriwaki Y; Ka T; Inokuchi T; Yamamoto A; Takahashi S; Tsutsumi Z; Tsuzita J; Oku Y; Yamamoto T
    Metabolism; 2006 Jan; 55(1):103-7. PubMed ID: 16324927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.